528 related articles for article (PubMed ID: 26979166)
1. Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders.
Kalkman HO; Feuerbach D
Cell Mol Life Sci; 2016 Jul; 73(13):2511-30. PubMed ID: 26979166
[TBL] [Abstract][Full Text] [Related]
2. The Recent Development of α7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases.
Beinat C; Banister SD; Herrera M; Kassiou M
Curr Pharm Des; 2016; 22(14):2134-51. PubMed ID: 26818858
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
Patel H; McIntire J; Ryan S; Dunah A; Loring R
J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
Beinat C; Banister SD; Herrera M; Law V; Kassiou M
CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3.
Mizrachi T; Vaknin-Dembinsky A; Brenner T; Treinin M
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684720
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease.
Wang S; Fang Y; Wang H; Gao H; Jiang G; Liu J; Xue Q; Qi Y; Cao M; Qiang B; Zhang H
Eur J Med Chem; 2018 Nov; 159():255-266. PubMed ID: 30296684
[TBL] [Abstract][Full Text] [Related]
7. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
Brunzell DH; McIntosh JM; Papke RL
Ann N Y Acad Sci; 2014 Oct; 1327(1):27-45. PubMed ID: 24730978
[TBL] [Abstract][Full Text] [Related]
8. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Faghih R; Gfesser GA; Gopalakrishnan M
Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations.
Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M
Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408
[TBL] [Abstract][Full Text] [Related]
10. The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?
Thomsen MS; Mikkelsen JD
Curr Drug Targets; 2012 May; 13(5):707-20. PubMed ID: 22300038
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Characterization of the Novel and Selective
Wang X; Daley C; Gakhar V; Lange HS; Vardigan JD; Pearson M; Zhou X; Warren L; Miller CO; Belden M; Harvey AJ; Grishin AA; Coles CJ; O'Connor SM; Thomson F; Duffy JL; Bell IM; Uslaner JM
J Pharmacol Exp Ther; 2020 May; 373(2):311-324. PubMed ID: 32094294
[TBL] [Abstract][Full Text] [Related]
12. Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.
Russo P; Del Bufalo A; Frustaci A; Fini M; Cesario A
Curr Pharm Des; 2014; 20(38):6014-21. PubMed ID: 24641224
[TBL] [Abstract][Full Text] [Related]
13. Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.
Quik M; Zhang D; McGregor M; Bordia T
Biochem Pharmacol; 2015 Oct; 97(4):399-407. PubMed ID: 26093062
[TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.
Bitner RS; Bunnelle WH; Anderson DJ; Briggs CA; Buccafusco J; Curzon P; Decker MW; Frost JM; Gronlien JH; Gubbins E; Li J; Malysz J; Markosyan S; Marsh K; Meyer MD; Nikkel AL; Radek RJ; Robb HM; Timmermann D; Sullivan JP; Gopalakrishnan M
J Neurosci; 2007 Sep; 27(39):10578-87. PubMed ID: 17898229
[TBL] [Abstract][Full Text] [Related]
15. Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.
Treinin M; Papke RL; Nizri E; Ben-David Y; Mizrachi T; Brenner T
Cent Nerv Syst Agents Med Chem; 2017; 17(2):90-99. PubMed ID: 27573666
[TBL] [Abstract][Full Text] [Related]
16. Central Activation of Alpha7 Nicotinic Signaling Attenuates LPS-Induced Neuroinflammation and Sickness Behavior in Adult but Not in Aged Animals.
Navarro E; Norden DM; Trojanowski PJ; Godbout JP; López MG
Molecules; 2021 Apr; 26(8):. PubMed ID: 33916910
[TBL] [Abstract][Full Text] [Related]
17. The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system.
Koukouli F; Maskos U
Biochem Pharmacol; 2015 Oct; 97(4):378-387. PubMed ID: 26206184
[TBL] [Abstract][Full Text] [Related]
18. Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.
Noda Y; Uchida M; Mouri A; Yamada S; Goto S; Kitagaki S; Mamiya T; Kushima I; Arioka Y; Ozaki N; Yoshimi A
Eur Neuropsychopharmacol; 2020 Dec; 41():92-105. PubMed ID: 33109433
[TBL] [Abstract][Full Text] [Related]
19. Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107.
Mizrachi T; Marsha O; Brusin K; Ben-David Y; Thakur GA; Vaknin-Dembinsky A; Treinin M; Brenner T
J Neuroinflammation; 2021 Apr; 18(1):99. PubMed ID: 33902624
[TBL] [Abstract][Full Text] [Related]
20. Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology.
Pohanka M
Int J Mol Sci; 2012; 13(2):2219-2238. PubMed ID: 22408449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
